This marks the second occasion when Teleflex’s offering has been chosen for the celebrated award. Earlier, the company’s Weck Hem-o-lok Auto Endo5 Ligation System had been recognized as one of the ...
Q4 2025 earnings call recap: divestitures, $1.8B proceeds, $1B buyback, 2026 EPS $6.25–$6.55, risks & outlook—read now.
(MENAFN- GlobeNewsWire - Nasdaq) The Vascular Access Devices Market Companies Quadrant delivers a thorough analysis of the global vascular access devices sector. Highlighting prominent players, ...
Q4 2025 Earnings Call February 26, 2026 8:00 AM ESTCompany ParticipantsLawrence Keusch - Vice President of Investor ...
Teleflex Incorporated has announced its agreement to acquire most of the Vascular Intervention business from BIOTRONIK SE & Co. KG for approximately €760 million, pending regulatory approvals and ...
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter 2025 financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 26, ...
Teleflex Incorporated ( TFX), a global leader in medical devices used in critical care and surgery, revealed that its Weck EFx Endo Fascial Closure System has been chosen by the Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results